Web Analytics

3 Latest Announced Rounds

  • $30,000,000
    Series B

    5 Investors

    Food and Beverage Services
    Nov 19th, 2024
  • $316,823
    Unknown

    1 Investors

    IT Services and IT Consulting
    Nov 19th, 2024
  • $7,200,000
    Seed

    1 Investors

    Software Development
    Nov 19th, 2024
$1,856.00M Raised in 85 Funding Rounds in the past 7 Days - View All

Funding Round Profile

B-Secur

start up
United Kingdom - Belfast
  • 01/11/2021
  • Unknown
  • $12,000,000

B-Secur is a heart health technology company.

Founded in Belfast, Northern Ireland, we are dedicated to addressing the world’s leading cause of death - cardiovascular disease.

We spent many years immersed in deep scientific research in EKG biometric security. This led us on a unique journey to develop heart health technology and drive better health outcomes for future generations.

Covid-19 has accelerated the pace of our innovation as the world of medical technology and consumer devices converge.

We have created HeartKey® 2.0, a suite of powerful EKG algorithms and analytics that enhances signal clarity, reduces signal noise, and delivers FDA-cleared health data with actionable wellness insights.

We partner with world-leading technology companies reducing time to market for next generation medical and consumer devices and platforms.

Our expertise in EKG coupled with deep experience in hardware, software and science enables our partners to tackle the fundamental healthcare issues of today.

Everything we do is with purpose. Health capital not wealth capital is what matters most and we are proud to play our part in driving better health and wellness outcomes for future generations.


Related People

Alan ForemanFounder

Alan Foreman United Kingdom - Bowdon, England,

Alan is a visionary tech entrepreneur who has built a highly successful career in the Healthcare Technology industries working with the world’s leading healthcare providers (pharmaceuticals, medical devices, private and public healthcare) and technology providers (software, hardware, platform, cybersecurity, consulting).

As co-founder and CEO of global heart health technology company, B-Secur, Alan is responsible for company strategy, building a world class team, driving partnerships and commercial success.

He has also orchestrated unprecedented levels of investment fund raising of any early-stage company in Northern Ireland, including raising investment in U.S., enabling B-Secur to advance a truly unique world's first technology.

Alan leads more than 75 experts at B-Secur including world-class scientists, leading engineers and experienced commercial executives at offices across the U.S., the UK and Ireland, with expanding customer bases in Europe, Americas and Asia.

B-Secur’s FDA-Cleared HeartKey technology is a world’s first which is revolutionising the way people experience technology, bringing personalised and preventative healthcare monitoring to everyone.

Prior to B-Secur, Alan spent almost twenty years at Future Global 500 company, Accenture plc, latterly as Managing Director, working in Products and Healthcare based industries with a strong focus on technology innovation. This involved working with many of the world’s leading technology providers including Microsoft, Apple, IBM, Cisco, EMC and Salesforce.

A prominent member of Northern Ireland’s burgeoning tech sector, Alan works closely with a number of prestigious UK universities including Queen’s University and Ulster University.

As a leading authority on UK entrepreneurship Alan sits on the UK Confederation of British Industry (CBI) Health Council. The council, made up of senior executives from CBI members leading businesses and industry groups across the health and life science sectors, steers CBI’s work to promote health as a major driver of wellbeing, productivity and prosperity and to enhance the competitiveness of the UK economy.

Alan is also a guest lecturer on entrepreneurship at the London School of Economics. He works closely with the Department of Trade and Industry (TDI) and other bodies in the UK and Ireland developing strategies for technology leadership.

His expert opinion is regularly called upon by international analysts and media in the MedTech industry and he has contributed to articles in Forbes, the BBC, TechCrunch and the Financial Times.